版本:
中国

BRIEF-Glycyx Pharmaventures and Valeant agree to terms of licensing agreement in oncology

March 15 Glycyx Pharmaventures :

* Glycyx Pharmaventures and Valeant Pharmaceuticals agree to binding terms of licensing agreement in the field of oncology

* Deal allows co to commercialize products containing Methylnaltrexone Bromide for oncology indications in countries outside US, Canada

* Glycyx would pay sales-based milestones and royalties to Valeant Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐